Clinical Trial Update: A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

This is a Phase 1 pediatric pharmacokinetics study of LY3209590 in Type 2 diabetes mellitus that has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• LY3209590 (LY3209590)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED